Send the link below via email or IM to invite your audienceCopy
Start the presentationStart presenting
- Invited audience will follow you as you navigate and present
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can view together your prezi
- Learn more about this feature in the manual
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.
Transcript of CHAARM
Anti-Retroviral Microbicides CHAARM is a large scale collaborative project
co-funded by the European Commission under
the 7th Framework Programme (FP7)
for Research and Technological Development
aimed at developing existing
and new microbicides as
topical agents, to reduce
transmission of HIV
01/01/2010 – 31/12/2014
Total budget: 17 m €
Microbicides Microbicides are compound that could be applied in the form of a gel, cream or a slow-release device so as to prevent infection with HIV at vaginal or rectal surfaces.
No microbicide has yet been approved for use although a number are being tested in clinical trials.
CHAARM develops new microbicides aimed at both established and new targets so as to help maintain a pipeline of promising candidates and will also develop combinations of microbicides.
Combining 2 or more microbicides in a single product may be much more effective than using a single microbicide and, importantly, may reduce the
likelihood of HIV becoming resistant to the product.
That is what CHAARM is aimed at. PRESS MICROBICIDES
HIV transmission CHAARM project
involves scientists with expertise in a wide range of different disciplines bringing together 31 institutions (Universities, Research Institutes, SMEs and larger industries in microbicides) in 12 countries, including 8 EU Member States, as well as Switzerland,Ukraine, South Africa and the United States of America.